Ocumension Therapeutics

Ophthalmic drugs, cancer cell therapies attract $340M+ on two HKEX biotech debuts
Endpoints
Fri, 07/10/20 - 10:52 am
biotech
IPOs
HKEX
Hong Kong
Ocumension Therapeutics
Immunotech Biopharm